Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.-Reference-Cited by-同舟云学术

Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.

Published:1984-08-25 Issue:6443 Volume:289 Page:468-469
ISSN:0959-8138
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Kerle D,Williams G,Ware H,Bloom S R

Publisher

BMJ

Subject

General Earth and Planetary Sciences,General Environmental Science,General Engineering

Reference5 articles.

1. Adverse reaction to ipratropium bromide;Connolly, C.K.;Br Med J,1982

2. Bronchoconstriction in response to ipratropium bromide. Br Med _';Patel, K.R.; Tullett, W.M.,1983

3. Bronchoconstriction in response to ipratropium bromide. Br MedJ3;Howarth, P.H.,1983

4. The effects of ultrasonically-produced aerosols on airways resistance in man;Cheney, F.W.; Butler, J.;Anesthesiology,1968

5. Bronchial reactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline;Schoeffel, R.E.; Anderson, S.D.; Altounyan, R.E.;Br,1981

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer;Anti-Cancer Drugs;2020-08-17

2. Bench-to-bedside development of agonists and antagonists of luteinizing hormone–releasing hormone for treatment of advanced prostate cancer;Urologic Oncology: Seminars and Original Investigations;2015-06

3. Agonists of luteinizing hormone-releasing hormone in prostate cancer;Expert Opinion on Pharmacotherapy;2013-08-28

4. Evidence-based medicine: comparative analysis of luteinizing hormone-releasing hormone analogues in combination with external beam radiation and surgery in the treatment of carcinoma of the prostate;BJU International;2010-11-15

5. ¿Se ha de asumir el efecto de clase farmacológica entre los diferentes análogos de la hormona liberadora de la hormona luteinizante usados en el tratamiento del carcinoma de próstata?;Actas Urológicas Españolas;2010-10